Categories: NewsPharmaceutical

Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TAMPA, Fla., April 30, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results after the close of the U.S. markets on Tuesday May 7, 2024. Following the release, the company will host a live conference call and webcast at 4:30 p.m. ET.

To participate in the conference call, dial 1-800-715-9871 and provide the passcode 6363041. International callers may dial 1-646-307-1963 and use the same passcode. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com.

About Pacira

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

CONTACT: Investor Contact:

Pacira BioSciences, Inc.
Christian Pedetti, (973) 254-4387
Christian.Pedetti@pacira.com

Staff

Recent Posts

Healthee Launches Smarter, Simpler, AI-Powered Benefits Platform

NEW YORK, June 25, 2025 /PRNewswire/ -- Healthee is proud to announce that the reimagined…

11 hours ago

Tobin Scientific Hires Graham Long as Chief Commercial Officer

Seasoned life sciences executive joins in key leadership role to support next phase of growth…

11 hours ago

Fortify Children’s Health Uses Oracle Health Data Intelligence to Enhance Pediatric Care Across Its Clinical Network

Virginia-based pediatric care network gains more complete picture of a child's health history, supports early…

11 hours ago

Elfie raises $12m to expand access to free digital therapeutics for all diseases

NEW YORK, June 25, 2025 /PRNewswire/ -- Elfie, the free digital health super-app that rewards people…

11 hours ago